Correlation Between Champions Oncology and Exscientia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Exscientia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Exscientia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Exscientia Ltd ADR, you can compare the effects of market volatilities on Champions Oncology and Exscientia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Exscientia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Exscientia.

Diversification Opportunities for Champions Oncology and Exscientia

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Champions and Exscientia is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Exscientia Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exscientia ADR and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Exscientia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exscientia ADR has no effect on the direction of Champions Oncology i.e., Champions Oncology and Exscientia go up and down completely randomly.

Pair Corralation between Champions Oncology and Exscientia

Given the investment horizon of 90 days Champions Oncology is expected to generate 0.79 times more return on investment than Exscientia. However, Champions Oncology is 1.26 times less risky than Exscientia. It trades about 0.21 of its potential returns per unit of risk. Exscientia Ltd ADR is currently generating about 0.02 per unit of risk. If you would invest  391.00  in Champions Oncology on September 1, 2024 and sell it today you would earn a total of  61.00  from holding Champions Oncology or generate 15.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy76.19%
ValuesDaily Returns

Champions Oncology  vs.  Exscientia Ltd ADR

 Performance 
       Timeline  
Champions Oncology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.
Exscientia ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Exscientia Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Exscientia is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Champions Oncology and Exscientia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Champions Oncology and Exscientia

The main advantage of trading using opposite Champions Oncology and Exscientia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Exscientia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exscientia will offset losses from the drop in Exscientia's long position.
The idea behind Champions Oncology and Exscientia Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets